OKLAHOMA CITY--(BUSINESS WIRE)--On June 3, 2019, a class action lawsuit was filed in the United States District Court for the Southern District of California against Heron Therapeutics, Inc. (NASDAQ: HRTX). Federman & Sherwood reminds current and former shareholders of Heron Therapeutics, Inc. that they only have until Monday, August 5, 2019 to move the court for appointment as a lead plaintiff in this case. The Complaint alleges violations of Section 10(b) and Section 20(a) of the Securities Exchange Act, and Rule 10b-5 promulgated thereunder.
If you purchased Heron Therapeutics, Inc. shares between October 31, 2018 and April 30, 2019, have large losses as a result of your trades during this time period, and wish to join this litigation as a potential lead plaintiff, please contact our office as soon as possible or visit: https://www.federmanlaw.com/blog/federman-sherwood-reminds-investors-of-imminent-lead-plaintiff-deadline-in-the-securities-class-action-lawsuit-against-heron-therapeutics-inc/
Our firm seeks to recover damages on behalf of the Class. Federman & Sherwood has extensive experience and expertise in prosecuting securities litigation involving financial fraud. We represent investors throughout the country in shareholder litigation.